{
  "configurations": [
    {
      "nodes": [
        {
          "cpeMatch": [
            {
              "criteria": "cpe:2.3:o:baxter:sigma_spectrum_infusion_system_firmware:6.05:*:*:*:*:*:*:*",
              "matchCriteriaId": "E6B02D87-6C75-4D60-8D4C-84628757214F",
              "vulnerable": true
            }
          ],
          "negate": false,
          "operator": "OR"
        },
        {
          "cpeMatch": [
            {
              "criteria": "cpe:2.3:h:baxter:sigma_spectrum_infusion_system:-:*:*:*:*:*:*:*",
              "matchCriteriaId": "49E25260-EC14-4E98-A86B-CBBE47E26AE5",
              "vulnerable": false
            },
            {
              "criteria": "cpe:2.3:h:baxter:wireless_battery_module:16:*:*:*:*:*:*:*",
              "matchCriteriaId": "175BDC61-5163-4D78-BF02-6B9EF5D38841",
              "vulnerable": false
            }
          ],
          "negate": false,
          "operator": "OR"
        }
      ],
      "operator": "AND"
    }
  ],
  "cveTags": [],
  "descriptions": [
    {
      "lang": "en",
      "value": "Baxter SIGMA Spectrum Infusion System version 6.05 (model 35700BAX) with wireless battery module (WBM) version 16 contains a hard-coded password, which provides access to basic biomedical information, limited device settings, and network configuration of the WBM, if connected. The hard-coded password may allow an attacker with physical access to the device to access management functions to make unauthorized configuration changes to biomedical settings such as turn on and off wireless connections and the phase-complete audible alarm that indicates the end of an infusion phase. Baxter has released a new version of the SIGMA Spectrum Infusion System, version 8, which incorporates hardware and software changes."
    },
    {
      "lang": "es",
      "value": "Baxter SIGMA Spectrum Infusion System 6.05 (modelo 35700BAX) con un módulo de batería inalámbrica (WBM), en su versión 16, contiene una contraseña embebida, lo que proporciona acceso a información biomédica básica, opciones del dispositivo limitadas y la configuración de red del WBM, si aplica. La contraseña embebida podría permitir que un atacante con acceso físico al dispositivo acceda a las funciones de gestión para hacer cambios no autorizados en la configuración a las opciones biomédicas, como encender y apagar las conexiones inalámbricas o una alarma audible que indica el final de una fase de inyección. Baxter ha publicado una nueva versión de SIGMA Spectrum Infusion System, la 8, que incluye cambios en el software y el hardware."
    }
  ],
  "id": "CVE-2014-5431",
  "lastModified": "2019-10-09T23:11:10.560",
  "metrics": {
    "cvssMetricV2": [
      {
        "acInsufInfo": false,
        "baseSeverity": "MEDIUM",
        "cvssData": {
          "accessComplexity": "LOW",
          "accessVector": "LOCAL",
          "authentication": "NONE",
          "availabilityImpact": "PARTIAL",
          "baseScore": 4.6,
          "confidentialityImpact": "PARTIAL",
          "integrityImpact": "PARTIAL",
          "vectorString": "AV:L/AC:L/Au:N/C:P/I:P/A:P",
          "version": "2.0"
        },
        "exploitabilityScore": 3.9,
        "impactScore": 6.4,
        "obtainAllPrivilege": false,
        "obtainOtherPrivilege": false,
        "obtainUserPrivilege": false,
        "source": "nvd@nist.gov",
        "type": "Primary",
        "userInteractionRequired": false
      }
    ],
    "cvssMetricV30": [
      {
        "cvssData": {
          "attackComplexity": "LOW",
          "attackVector": "PHYSICAL",
          "availabilityImpact": "HIGH",
          "baseScore": 6.8,
          "baseSeverity": "MEDIUM",
          "confidentialityImpact": "HIGH",
          "integrityImpact": "HIGH",
          "privilegesRequired": "NONE",
          "scope": "UNCHANGED",
          "userInteraction": "NONE",
          "vectorString": "CVSS:3.0/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H",
          "version": "3.0"
        },
        "exploitabilityScore": 0.9,
        "impactScore": 5.9,
        "source": "nvd@nist.gov",
        "type": "Primary"
      }
    ]
  },
  "published": "2019-03-26T16:29:00.243",
  "references": [
    {
      "source": "ics-cert@hq.dhs.gov",
      "tags": [
        "Mitigation",
        "US Government Resource",
        "Third Party Advisory"
      ],
      "url": "https://ics-cert.us-cert.gov/advisories/ICSA-15-181-01"
    }
  ],
  "sourceIdentifier": "ics-cert@hq.dhs.gov",
  "vulnStatus": "Modified",
  "weaknesses": [
    {
      "description": [
        {
          "lang": "en",
          "value": "CWE-798"
        }
      ],
      "source": "nvd@nist.gov",
      "type": "Primary"
    },
    {
      "description": [
        {
          "lang": "en",
          "value": "CWE-259"
        }
      ],
      "source": "ics-cert@hq.dhs.gov",
      "type": "Secondary"
    }
  ]
}